Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference48 articles.
1. Molecular portraits of human breast tumours;Perou;Nature,2000
2. Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer;Andre;Clin Canc Res,2013
3. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression;DeNardo;Breast Canc Res,2007
4. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer;Denkert;J Clin Oncol,2010
5. GBG and AGO-B study groups. RNA-based molecular tumor typing and immunological infiltrate as response predictors to neoadjuvant chemotherapy: pro- spective validation in the GeparQuinto-PREDICT substudy;Denkert;J Clin Oncol,2011
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic Value of “Basal-like” Morphology, Tumor-Infiltrating Lymphocytes and Multi-MAGE-A Expression in Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2024-04-20
2. Targeting PRAME for acute myeloid leukemia therapy;Frontiers in Immunology;2024-03-26
3. PRAME expression and its prognostic significance in invasive breast carcinoma;Pathology - Research and Practice;2024-02
4. Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma in vitro;Translational Cancer Research;2024-01
5. DNA damage response and neoantigens: A favorable target for triple-negative breast cancer immunotherapy and vaccine development;International Review of Cell and Molecular Biology;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3